Last CNY38.86 CNY
Change Today -0.89 / -2.24%
Volume 1.5M
600211 On Other Exchanges
Symbol
Exchange
Shanghai
As of 2:05 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by TIBET RHODIOLA PHARM-A (600211) in the last 6 months

Announced 10/30/14
785.00M for Tibet Rhodiola Pharmaceutical Holding Company
Merger/Acquisition

Shenzhen Kangzhe Pharmaceutical Technology Development Co., Ltd. signed an agreement to acquire additional 17.97% stake in Tibet Rhodiola Pharmaceutical Holding Company (SHSE:600211) from Beijing New Phoenix Properties Development Limited, Tibet TongYing Investment Co., Ltd. and Tianjin Tongsheng Investment Co. Ltd. for approximately CNY 780 million in cash on October 29, 2014. The consideration is subject to adjustments. Kangzhe Pharmaceutical will acquire 13.73%, 3.09% ...
Read More


600211's price was unchanged after the transaction was announced on 10/30/14.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600211:CH CNY38.86 CNY -0.89

600211 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600211.
View Industry Companies
 

Industry Analysis

600211

Industry Average

Valuation 600211 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 127.6x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIBET RHODIOLA PHARM-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.